A pharmacist or practitioner who proposes to make any substitution must have made use of a list of biologically equivalent drugs or interchangeable biological products approved by the United States Food and Drug Administration.
(Added to NRS by 1979, 1349; A 1989, 1122; 1993, 635; 2017, 636)